23andMe customer? Here's what to know about the privacy of your genetic data.
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
23andMe is ending its cancer research program and slashing over 200 jobs
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
What 23andMe business troubles could mean for millions of users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
23andMe says it faces financial hardships and has doubts it can still operate
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...
23andMe cuts 40% of its workforce
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
23andMe宣布重组并转变重点
23andMe Holding Co.（纳斯达克股票代码：ME）在最近的财报电话会议上概述了战略转变，强调削减成本并转向基于订阅的收入和制药合作伙伴关系。公司的重组努力，包括大幅裁员和终止治疗项目，是提高长期可持续性和财务健康的更广泛战略的一部分。尽管面临收入和现金储备下降的问题，23andMe正在采取措施改善其财务状况并重新获得投资者信心。
23andMe cuts 40% of its workforce and discontinues therapeutics division
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
ABC 7 Chicago13 小时
What 23andMe business troubles could mean for users' genetic data
In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...
23andMe cuts 40% of its workforce, discontinues all therapy programs
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe股价下跌，第二季度亏损扩大尽管收入超预期
加利福尼亚州桑尼维尔 - 23andMe Holding Co. (NASDAQ:ME) 公布的2024财年第二季度亏损超出预期，尽管收入超过预估，导致盘后交易中股价下跌1.74%。 这家基因和预防性健康公司在截至9月30日的季度内每股亏损2.32美元，远高于分析师预期的每股亏损0.16美元。然而，收入达到4407万美元，超过了3641万美元的一致预期。
腾讯网2 天
美国基因技术公司23andMe宣布裁员40%
美国基因技术公司23andMe当地时间11月11日宣布进行业务重组，以精简业务和降低成本。此外，23andMe将停止所有治疗项目的进一步开发。23andMe称，公司将减少200多名员工，约占员工总数的40%。业务重组预计将大幅减少运营开支，每年可节省超过3500万美元的成本。公司预计将产生多至1200万美元的成本和费用，主要与一次性遣散 ...
23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...